Research Library
PRECLINICAL

GHK-Cu (Copper Peptide)

Also known as: GHK-Cu, Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper

Tissue BiologyPeptide Signaling
ClassificationCopper-binding tripeptide complex.
Catalog / SKUGHK-Cu (Copper Peptide) · MX-GHKCUCOP-100 · 100 mg
TargetsCopper transport / cellular signalling (experimental)

Molecular Overview

GHK-Cu is a naturally occurring copper-binding tripeptide (GHK) complexed with copper, studied in cellular and tissue-biology research and gene-expression models.

Mechanistic Background

GHK-Cu is examined for copper delivery and effects on cellular signalling and gene-expression programs in experimental systems.

What Researchers Study

Preclinical research has examined roles in tissue-biology and gene-expression models.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Most evidence is preclinical/in-vitro.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.